Skip to content

Validation of the Paediatric Electronic quality of Life Instrument for Childhood Asthma in the Netherlands.

Validation of the Paediatric Electronic quality of Life Instrument for Childhood Asthma in the Netherlands. - Pelican project

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32237
Enrollment
275
Registered
2008-10-17
Start date
2008-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma bronchial asthma

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: For the asthmatic children * age 4 to 12 years * signed informed consent by parent (or caretaker) * child agrees to participate in the study * at least two prescriptions for inhaled asthma medication during the previous year * use of inhaled asthma medication for at least six weeks during the previous year * physician-diagnosed asthma (a symptom diagnose asthma by a physician in case the child is 4 or 5 years old ) ;For the healthy individuals (reference population) * age 6 to 12 years * signed informed consent by parents (or caretakers) * child agrees to participate in the study

Exclusion criteria

Exclusion criteria: For all children * comorbid condition that significantly influences HRQL * child does not master the Dutch language sufficiently * not being able to attend a regular school class

Design outcomes

Primary

MeasureTime frame
The Pelican instrument should have the following (clinimetric) characteristics: has a high internal consistency and is able to detect relevant changes in HRQL within an individual child aged 6 to 12 years (evaluative capacity of the instrument). Moreover, the validity of the individualised part of the instrument should be good and the instrument is comprehendible, serviceableness and acceptable according to the children.

Secondary

MeasureTime frame
The Pelican instrument should have the following (clinimetric) characteristics: is able to discriminate between relevant groups; is valid based on cross-sectional construct validity; is reliable and valid for children with asthma aged 4 or 5. Next the influence of a reminder on the reliability of the children*s answers will be evaluated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)